Trial Profile
A Retrospective study to evaluate the safety and efficacy of intravitreal ocriplasmin followed by pars plana virectomy in patients with vitreomacular traction with or without macular hole
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2017
Price :
$35
*
At a glance
- Drugs Ocriplasmin (Primary)
- Indications Retinal disorders
- Focus Therapeutic Use
- Acronyms VAVOOM
- 01 Jun 2017 New trial record